SO TO RECAP:
COMPANY ON THE CUTTING EDGE OF THE NEXT BIG BUBBLE IN MEDICAL TREATMENT (THAT OF POTENTIAL CURES INSTEAD OF ENDLESS PHARMACEUTICALS) IN
HEART
LUNGS
LIVER
SOFT TISSUE
CARTILAGE
WITH QUARTER OVER QUARTER OVER QUARTER OVER QUARTER OF INCREASING REVENUES, LESS EXPENSES
GREAT FINS! (For any company, no matter a penny stock)
NO CONTRAVERTIBLE DEBT, AND NO DILUTION (WITH PROMISE OF NO TOXIC DEBT FINANCING GOING FORWARD)
KRISTEN COMELLA AS CSO WHO PUBLISHES PAPERS ON THE SUBJECT MORE OFTEN THAN SOME OF US GO OUT TO EAT, GETTING NATIONAL SCIENCE AND MEDICAL ATTENTION AND ACKNOWLEDGEMENT FROM HER PEERS AND THOSE COMMUNITIES AT LARGE
STRATEGIC PARTNERSHIP WITH GACP WHO ARE MOVING FORWARD RAPIDLY OPENING CLINICS INCLUDING DALLAS TO WIT, WE HAVE PERCENTAGE INTEREST AND INCREASED REVENUE ACTUALLY AND POTENTIALLY.
RTT IN TX ALREADY PASSED, GOLD MINE FOR NEWEST CLINIC. FLORIDA NEW CLINIC COMING SOON, AS IS
DENVER
AND HUGE ONE IN KUWAIT.
COUNTLESS POSITIVE TESTIMONIALS FROM PATIENTS INCLUDING CELEBS, ATHLETES, AND GENERAL POPULATION, WITH INCREASING ACCEPTANCE AND AWARENESS.
AND THE FDA "WARNING" LETTER ISSUE ALREADY RESPONDED TO BRILLIANTLY AND TIMELY, WITH A 'WILLING TO WORK WITH YOU', BUT DONT OVERSTEP OR WE'LL HAVE THE AMERICAN CITIZENRY UP YOUR BUTTS' KINDA ATTITUDE.
ALL THIS FOR THE PRICE OF .02, WHICH TO USE THE TERM "UNDERVALUED" OR "OVERSOLD" IS LIKE SAYING
THE PACIFIC OCEAN IS ....MOIST
OR
HURRICANE IRMA IS A BIT.....BREEZY.
ON CURRENT (LAST QTR) REVENUES ALONE THIS SHOULD BE AT .12-.13
Buy now. Load up!
